This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In 2023, there were significant advancements and notable trends in the lifesciences. Xtalks compiled a list of its top lifescience news and trends of 2023, which provided readers with the latest developments, information and expert insights across lifescience industries, including pharma, biotech and medical device.
Every major pharmacompany is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. This is a primary factor for the staggeringly high unit cost of CGT.
Since the onset of the Covid-19 pandemic, lifesciencecompanies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). For the most part, lifesciencecompanies have a relatively good knowledge of what their audiences want and need from them.
The past two years have shone a spotlight on the UK lifesciences industry. Pharmacompanies are now household names, having been thrust into the public’s consciousness after dominating the headlines through the pandemic. An industry that will forever play a greater role in our everyday lives. About the author.
For the innovators and early adopters of the lifesciences industry, engineering a regulatory-grade ECA can be daunting. However, if history is any indication, pharmacompanies have been risk-averse when it comes to fully immersing itself into the expanded use of RWE in our development efforts. About the authors.
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharmacompanies in the world: AstraZeneca.
Sun says Komodo’s Healthcare Map has been built over the last seven and a half years and contains so much information that can help identify and treat patients with rare diseases. During the pandemic, numerous digital health companies flourished due to the necessity for virtual solutions, including Komodo Health. About the author.
In light of the benzene contamination, “While the use of these products would not be expected to cause adverse health consequences,” the company says it was the “right decision” to ask customers to stop using them. Growing Contamination Issues. And last month, sanofi-aventis Canada Inc.
The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’ But a closer inspection of the EU-UK Trade and Cooperation Agreement (TCA) renders these statements largely illusory for the pharma sector. The Medicinal Products Annex.
This included segregated wards at Johns Hopkins containing Black patients with cervical cancer whom white doctors would collect samples from without their knowledge or consent. However, the agreement did not include a share of any profits that researchers or pharmacompanies may make from use of the cells.
The first class of Immuno-STAT molecules from Cue Biopharma contain an epitope-targeted peptide-HLA complex (signal 1) and a T cell activator i.e. molecules of IL-2 (signal 2) on an Fc antibody backbone. Image from Cue Biopharma. The Immuno-STAT Molecules. The T cell epitope is usually an 8 – 10 amino acid peptide.
While weight loss service providers such as Weight Watchers and Noom have begun to offer Zepbound and Wegovy through their telehealth services, pharmacompanies focus on the development and manufacturing side of things and don’t typically involve themselves in home delivery of drugs or connecting patients, providers and pharmacies.
Moreover, samples for the SalivaDirect test can be collected in any sterile container, and hence does not require any specific type of swab or collection vessel, making collection quick and easy. The diagnostic test has some unique features, including a novel method of processing saliva samples to test for COVID-19 infection.
Now, let’s delve into the list of the top ten fastest growing biotech companies in 2023, ranked by their compound annual growth rate (CAGR). These companies were identified through The Americas’ Fastest-Growing Companies 2023 list by the Financial Times.
The Government of India in order to contain the spread of novel coronavirus rolled out several guidelines and precautionary measures. British-Swedish pharmacompany AstraZeneca in collaboration with Jenner Institute (Oxford University) is working on Covid-19 vaccine ChAdOx1 nCoV-19 /AZD1222. Zydus Cadila ( ZyCoV-D ).
Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the NHS Innovation and LifeSciences Commission Report launch took place at One Great George Street, Westminster, on 12th December 2022. The UK as a powerhouse of research.
“Biologics products may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system.
The ad seemingly displays Lilly’s commitment to health and medical treatments as a pharmacompany. Xolair, Caregiver As part of Novartis and Genentechs national campaign Accidents Happen, Caregiver is one of two ads for the companies asthma and allergy drug Xolair (omalizumab). Lilly spent about $12.1
billion in total sales for 2022, the most ever reported by any pharmacompany in a single year. billion Company/developer: Janssen Pharmaceuticals Date of first FDA approval: June 23, 2006 FDA-approved indications : Prezista is indicated for the treatment of HIV-1 infection. The following year saw sales edge up to $37.8
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content